Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details